Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Moller HJ, Rogers SL, Friedhoff LT (1999)
The effects of donepezil in Alzheimer's disease - results from a multinational trial
Dementia & Geriatric Cognitive Disorders 10: 237
Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT (1998)
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses
British Journal of Clinical Pharmacology 46 Suppl 1: 7
Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998)
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group
Archives of Internal Medicine 158: 1021
Rogers SL, Friedhoff LT (1998)
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses
British Journal of Clinical Pharmacology 46 Suppl 1: 1
Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998)
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
Neurology 50: 136
Rogers SL, Friedhoff LT (1998)
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
European Neuropsychopharmacology 8: 67
Rogers SL (1998)
Perspectives in the Management of Alzheimer's Disease: Clinical Profile of Donepezil
Dementia & Geriatric Cognitive Disorders 9: 29
Tiseo PJ, Rogers SL, Friedhoff LT (1998)
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration
British Journal of Clinical Pharmacology 46 Suppl 1: 13
Rogers SL, Friedhoff LT (1996)
The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo- Controlled Trial. The Donepezil Study Group
Dementia 7: 293